Product Description: Antileishmanial agent-29 (Compound 110) is an orally active antileishmanial agent. Antileishmanial agent-29 (p.o., 40, 60 mg/kg, 10 days) protects mice from leishmania infection[1].
Applications: COVID-19-immunoregulation
Formula: C20H29N3
References: [1]Kancharla P, et al. Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial Agents. J Med Chem. 2024 May 9.
Molecular Weight: 311.46
Research Area: Infection
Solubility: 10 mM in DMSO
Target: Parasite